Although it is unclear how this interaction would lead to disease, this proposed mechanism is supported by the fact that altered patterns of VWF multimers are found to occur frequently in patients with thrombotic thrombocytopenic purpura in the acute and chronic stages, which shares some clinical and laboratory findings with PE including thrombocytopenia. The gene discussed is VWF; the disease is thrombotic thrombocytopenic purpura.